Imbruvica Alternatives Compared
| Imbruvica Remove Imbruvica from your drug comparison | Ibrutinib Remove Ibrutinib from your drug comparison | Rituxan Remove Rituxan from your drug comparison |
|---|
| Imbruvica ibrutinib Remove Imbruvica from your drug comparison | Ibrutinib Remove Ibrutinib from your drug comparison | Rituxan rituximab Remove Rituxan from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers. It works by inhibiting the enzyme Bruton tyrosine kinase (BTK) which is part of a crucial signaling... View more |
Prescribed for Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Lymphoma, Non-Hodgkin's Lymphoma, Graft-versus-host disease. ibrutinib may also be used for purposes... View more |
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
||||||||||||||||||
Drug Class |
||||||||||||||||||
Side Effects |
||||||||||||||||||
|
Common side effects include: infection, anemia, neutropenia, thrombocytopenia, bruise, cytopenia. See the full Imbruvica side effects document. |
Commonly reported side effects include: infection, anemia, neutropenia, thrombocytopenia, bruise, cytopenia. See the full ibrutinib side effects document. |
See the full Rituxan side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||
View all Imbruvica prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rituxan prices |
||||||||||||||||
Generic Availability |
||||||||||||||||||
|
No |
No |
No |
||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names |
||||||||||||||||||
|
N/A |
Imbruvica | Other rituximab brands include: Riabni, Ruxience, Truxima | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||
|
6 hours |
6 hours |
59.8 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
||||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
||||||||||||||||||
|
A total of 384 drugs are known to interact with Imbruvica:
|
A total of 384 drugs are known to interact with ibrutinib:
|
A total of 132 drugs are known to interact with Rituxan:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
||||||||||||||||||
First Approval Date |
||||||||||||||||||
|
November 13, 2013 |
November 13, 2013 |
N/A |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
More Information |
||||||||||||||||||
Consumer Resources |
||||||||||||||||||
Professional Resources |
||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.